$125 | Single User
$250 | Site License
$375 | Global License

Mundipharma International Ltd - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

Published by Global Data: 31 Jan 2019 | 230731 | In Stock

Introduction

Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Mundipharma International Ltd (Mundipharma) conducts research and develops products for the treatment pain management, respiratory, cancer and inflammatory conditions. The company commercializes and launches products within Europe and rest of the world. Mundipharma offers its products through its network of subsidiaries, independent associated companies, partners and joint ventures. The company’s network includes Napp Pharmaceuticals, Norpharma and the Mundipharma independent associated companies. The company provides its services to patients, healthcare professionals and health systems worldwide. It has operations in Australia, Japan, New Zealand, Russia, Singapore, Philippines, South Africa, South Korea, Canada, China and USA. Mundipharma is headquartered in Cambridge, the UK.

Mundipharma International Ltd Key Recent Developments

Dec 03,2018: Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI IV by the National Medical Products Administration (NMPA)

Nov 30,2018: Mundipharma announces Marco Cerato as Senior Vice President Business Development and Strategic Partnerships

Nov 19,2018: Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan

Nov 19,2018: Mundipharma announces Chief Financial Officer

Oct 05,2018: Mundipharma announces Philippe Bastide as Head of Biosimilars

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Mundipharma International Ltd - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Section 1 - About the Company 5

    Mundipharma International Ltd - Key Facts 5

    Mundipharma International Ltd - Key Employees 6

    Mundipharma International Ltd - Key Employee Biographies 7

    Mundipharma International Ltd - Major Products and Services 8

    Mundipharma International Ltd - History 10

    Mundipharma International Ltd - Locations And Subsidiaries 13

    Head Office 13

    Other Locations & Subsidiaries 13

    Joint Venture 16

    Section 2 – Company Analysis 17

    Company Overview 17

    Mundipharma International Ltd - Business Description 18

    Mundipharma International Ltd - Corporate Strategy 19

    Mundipharma International Ltd - SWOT Analysis 20

    SWOT Analysis - Overview 20

    Mundipharma International Ltd - Strengths 20

    Mundipharma International Ltd - Weaknesses 21

    Mundipharma International Ltd - Opportunities 22

    Mundipharma International Ltd - Threats 23

    Mundipharma International Ltd - Key Competitors 24

    Section 3 – Company’s Lifesciences Financial Deals and Alliances 25

    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25

    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26

    Mundipharma International Ltd, Recent Deals Summary 27

    Section 4 – Company’s Recent Developments 28

    Dec 03, 2018: Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI IV by the National Medical Products Administration (NMPA) 28

    Nov 30, 2018: Mundipharma announces Marco Cerato as Senior Vice President Business Development and Strategic Partnerships 29

    Nov 19, 2018: Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan 30

    Nov 19, 2018: Mundipharma announces Chief Financial Officer 31

    Oct 05, 2018: Mundipharma announces Philippe Bastide as Head of Biosimilars 32

    Section 5 – Appendix 33

    Methodology 33

    About GlobalData 33

    Contact Us 33

    Disclaimer 33

List Of Tables
in Mundipharma International Ltd - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

List of Tables

Mundipharma International Ltd, Key Facts 5

Mundipharma International Ltd, Key Employees 6

Mundipharma International Ltd, Key Employee Biographies 7

Mundipharma International Ltd, Major Products and Services 8

Mundipharma International Ltd, History 10

Mundipharma International Ltd, Subsidiaries 13

Mundipharma International Ltd, Joint Venture 16

Mundipharma International Ltd, Key Competitors 24

Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25

Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26

Mundipharma International Ltd, Recent Deals Summary 27

List Of Figures, Charts and Diagrams
in Mundipharma International Ltd - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

List of Figures

Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25

Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 26

Additional Details

Publisher

Global Data

Publisher Information

Reference

230731 | GDPH67366SA

Number of Pages

33

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Mundipharma Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma Pte Ltd(Mundipharma) is a subsidiary of Mundipharma International Ltd, is a pharm...
14 Dec 2018 by Global Data USD $250 More Info
Mundipharma International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma International Ltd (Mundipharma) engages in the research and development of produc...
13 Nov 2018 by Global Data USD $250 More Info
Mundipharma International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma International Ltd (Mundipharma) researches and develops products for the treatmen...
20 Mar 2017 by Global Data USD $250 More Info
Mundipharma International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma International Ltd (Mundipharma) researches and develops products for the treatmen...
25 Nov 2016 by Global Data USD $250 More Info
Mundipharma International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma International Limited (Mundipharma) researches and develops products for the trea...
24 Aug 2016 by Global Data USD $250 More Info
Mundipharma International Ltd - Strategic SWOT Analysis Review
Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into...
10 May 2016 by Global Data USD $300 More Info
Mundipharma International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma International Limited (Mundipharma) researches and develops products for the trea...
15 Apr 2016 by Global Data USD $250 More Info
Mundipharma International Ltd - Strategic SWOT Analysis Review
Mundipharma International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into...
15 Mar 2016 by Global Data USD $300 More Info
Mundipharma International Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and In...
10 Mar 2016 by Marketline USD $350 More Info
Mundipharma International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMundipharma International Limited (Mundipharma) research, develops, manufactures and commerci...
08 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Mundipharma International Ltd - Strategic SWOT Analysis Review [Report Updated: 31-01-2019] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data